Between Bedside and Bench | Published:

Immune modulation: IL-1, master mediator or initiator of inflammation

Nature Medicine volume 15, pages 13631364 (2009) | Download Citation

Subjects

There are many ways to modulate the immune response in a therapeutic setting. Drugs that target the proinflammatory mediator IL-1, for instance, can counteract disease in certain types of inflammatory conditions. But such drugs do not work well for other conditions, such as rheumatoid arthritis and other autoimmune diseases. New clinical studies, examined by Kingston Mills and Aisling Dunne, provide insight into this discrepancy. Another approach that has worked well in mice harnesses the ability of regulatory T cells to dampen the immune response. But one barrier in the way of successful application to people is the ability of such cells to change their character for the worse. Massimo Gadina and John O'Shea take a look at a basic research study that highlights this dilemma and examine what it means for the future of human trials.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Annu. Rev. Immunol. 27, 519–550 (2009).

  2. 2.

    , , & Annu. Rev. Immunol. 27, 621–668 (2009).

  3. 3.

    et al. N. Engl. J. Med. 360, 2426–2437 (2009).

  4. 4.

    et al. N. Engl. J. Med. 360, 2438–2444 (2009).

  5. 5.

    , & Nat. Rev. Drug Discov. 8, 465–479 (2009).

  6. 6.

    , & Mol. Cell 10, 417–426 (2002).

  7. 7.

    , , , & J. Exp. Med. 203, 1685–1691 (2006).

  8. 8.

    Eur. J. Immunol. 38, 2636–2649 (2008).

  9. 9.

    et al. Immunity 31, 331–341 (2009).

  10. 10.

    et al. Immunity 30, 875–887 (2009).

  11. 11.

    , , , & Immunity 30, 860–874 (2009).

  12. 12.

    J. Leukoc. Biol. 81, 1–5 (2007).

Download references

Author information

Affiliations

  1. Kingston H.G. Mills and Aisling Dunne are in the Immune Regulation Research Group and Immunology Research Centre, School of Biochemistry and Immunology, Trinity College, Dublin, Ireland.

    • Kingston H G Mills
    •  & Aisling Dunne

Authors

  1. Search for Kingston H G Mills in:

  2. Search for Aisling Dunne in:

Competing interests

K.H.G.M. is a cofounder, minority shareholder, consultant, and scientific advisory board member of Opsona Therapeutics, Ltd.

Corresponding author

Correspondence to Kingston H G Mills.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm1209-1363

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing